Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return 17/04/2023 (VOVWORLD) - An experimental mRNA cancer vaccine developed by Moderna and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's...